Cas:433920-89-9 2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde manufacturer & supplier

We serve Chemical Name:2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde CAS:433920-89-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde

Chemical Name:2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde
CAS.NO:433920-89-9
Synonyms:2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde
Molecular Formula:C9H6FN3O
Molecular Weight:191.16200
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:47.78000
Exact Mass:191.04900
LogP:1.21890

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde Use and application,2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde technical grade,usp/ep/jp grade.


Related News: Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. 2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde manufacturer U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year. 2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde supplier Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. 2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde vendor Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large. 2-fluoro-4-(1,2,4-triazol-1-yl)benzaldehyde factory Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.